Role of estrogen in angiogenesis in cardiovascular diseases

Journal of Geriatric Cardiology

Volumn 10, Issue 4, 2013, Pages 377-382

  Barnabas, Oche ^a   Wang, Hong ^a   Gao, Xiu Mei ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Angiogenesis; Cardiovascular diseases; Estrogen; Estrogen receptors; Vascular endothelial growth factor

Indexed keywords

ESTROGEN; GROWTH FACTOR; VASCULOTROPIN;

ANGIOGENESIS; CARDIOVASCULAR DISEASE; HUMAN; PHYSIOLOGICAL PROCESS; REVIEW;

EID: 84892705248     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1671-5411.2013.04.008     Document Type: Review

References (50)

1. Ushio-Fukai M. Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovasc Res 2006;71:226-235.
2. Boosani CS, Sudhakar YA. Proteolytically Derived Endogenous Angioinhibitors Originating from the Extracellular Matrix. Pharmaceuticals (Basel). 2011;4:1551-1577.
3. Rey S, Semenza GL. Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res 2010;86:236-242.
4. Ziello JE, Jovin IS, Huang Y. Hypoxia-Inducible Factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia. Yale J Biol Med 2007;80:51-60.
5. Bellou S, Karali E, Bagli E, et al. The isoflavone metabolite 6-methoxyequol inhibits angiogenesis and suppresses tumor growth. Mol Cancer 2012;11:35.
6. Higuchi S, Ohtsu H, Suzuki H, et al. Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clin Sci (Lond) 2007;112:417-428.
7. Iwakura A, Shastry S, Luedemann C, et al. Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9. Circulation 2006;113:1605-1614.
8. Murphy E. Estrogen signaling and cardiovascular disease. Circ Res 2011;109:687-696.
9. Shanle EK, Xu W. Endocrine disrupting chemicals targeting estrogen receptor signaling: identification and mechanisms of action. Chem Res Toxicol 2011;24:6-19.
10. Tsutsumi S, Zhang X, Takata K, et al. Differential regulation of the inducible nitric oxide synthase gene by estrogen receptors 1 and 2. J Endocrinol 2008;199:267-273.
11. Liao WX, Magness RR, Chen DB. Expression of estrogen receptors-alpha and -beta in the pregnant ovine uterine artery endothelial cells in vivo and in vitro. Biol Reprod 2005;72:530-537.
12. Deroo BJ, Korach KS. Estrogen receptors and human disease. J Clin Invest 2006;116:561-570.
13. Srivastava N, Chowdhury PR, Averna M, et al. Estrogen increases hepatic lipase levels in inbred strains of mice: a possible mechanism for estrogen-dependent lowering of high density lipoprotein. Mol Cell Biochem. 2001;220:87-93.
14. Bagatell CJ, Knopp RH, Rivier JE, et al. Physiological levels of estradiol stimulate plasma high density lipoprotein2 cholesterol levels in normal men. J Clin Endocrinol Metab 1994;78:855-861.
15. Zhang K, Lu J, Mori T, et al. Baicalin increases VEGF expression and angiogenesis by activating the ERR {alpha}/PGC-1 {alpha} pathway. Cardiovasc Res 2011;89:426-435.
16. Secomb TW, Alberding JP, Hsu R, et al. Angiogenesis: an adaptive dynamic biological patterning problem. PLoS Comput Biol 2013;9:e1002983.
17. Albrecht ED, Babischkin JS, Lidor Y, et al. Effect of estrogen on angiogenesis in co-cultures of human endometrial cells and microvascular endothelial cells. Hum Reprod 2003;18:2039-2047.
18. Vu TH, Werb Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev 2000;14:2123-2133.
19. Ikeda K, Nakano R, Uraoka M, et al. Identification of ARIA regulating endothelial apoptosis and angiogenesis by modulating proteasomal degradation of cIAP-1 and cIAP-2. Proc Natl Acad Sci U. S. A. 2009;106:8227-8232.
20. Scarabin-Carre V, Canonico M, Brailly-Tabard S, et al. High level of plasma estradiol as a new predictor of ischemic arterial disease in older postmenopausal women: the three-city cohort study. J Am Heart Assoc 2012;1:e001388.
21. Lin AD, Mannikarottu A, Kogan BA, et al. Estrogen induces angiogenesis of the female rabbit bladder. J Endocrinol 2006;190:241-246.
22. Zhu W, Saddar S, Seetharam D, et al. The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity. Circ Res 2008;102:480-487.
23. Elkin M, Orgel A, Kleinman HK. An angiogenic switch in breast cancer involves estrogen and soluble vascular endothelial growth factor receptor 1. J Natl Cancer Inst 2004;96:875-878.
24. Jesmin S, Mowa CN, Sultana SN, et al. Estrogen receptor alpha and beta are both involved in the cerebral VEGF/Akt/NO pathway and cerebral angiogenesis in female mice. Biomed Res 2010;31:337-346.
25. Zachary I, Gliki G. Signal transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res 2001;49:568-581.
26. Powers CJ, McLeskey SW, Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 2000;7:165-197.
27. Johns A, Freay AD, Fraser W, et al. Disruption of estrogen receptor gene prevents 17 beta estradiol-induced angiogenesis in transgenic mice. Endocrinology 1996;137:4511-4513.
28. Newman AC, Nakatsu MN, Chou W, et al. The requirement for fibroblasts in angiogenesis: fibroblast-derived matrix proteins are essential for endothelial cell lumen formation. Mol Biol Cell 2011;22:3791-3800.
29. O'Lone R, Knorr K, Jaffe IZ, et al. Estrogen receptors alpha and beta mediate distinct pathways of vascular gene expression, including genes involved in mitochondrial electron transport and the generation of reactive oxygen species. Mol Endocrinol 2007;21:1281-1296.
30. Baruscotti I, Barchiesi F, Jackson EK, et al. Estradiol stimulates capillary formation of human endothelial progenitor cells: role of estrogen receptor-{alpha}/{beta}, heme oxygenase 1, and tyrosine kinase. Hypertension 2010;56:397-404.
31. Masuda H, Kalka C, Takahashi T, et al. Estrogen-mediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis. Circ Res 2007;101:598-606.
32. Jazbutyte V, Arias-Loza PA, Hu K, et al. Ligand-dependent activation of ER {beta} lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized spontaneously hypertensive rats. Cardiovasc Res 2008;77:774-781.
33. Chakrabarti S, Davidge ST. G-protein coupled receptor 30 (GPR30): a novel regulator of endothelial inflammation. PLoS One 2012;7:e52357.
34. Lenhart PM, Broselid S, Barrick CJ, et al. G-protein-coupled receptor 30 interacts with receptor activity-modifying protein 3 and confers sex-dependent cardioprotection. J Mol Endocrinol. 2013;51:191-202.
35. Plante BJ, Lessey BA, Taylor RN, et al. G protein-coupled estrogen receptor (GPER) expression in normal and abnormal endometrium. Reprod Sci 2012;19:684-693.
36. Seok YM, Jang EJ, Reiser O, et al. 17beta-Estradiol induces vasorelaxation in a G-protein-coupled receptor 30-independent manner. Naunyn Schmiedebergs Arch Pharmacol 2012;385:945-948.
37. Zhai P, Eurell TE, Cooke PS, et al. Myocardial ischemia-reperfusion injury in estrogen receptor-alpha knockout and wild-type mice. Am J Physiol Heart Circ Physiol 2000;278:H1640-H1647.
38. Wang M, Wang Y, Weil B, et al. Estrogen receptor beta mediates increased activation of PI3K/Akt signaling and improved myocardial function in female hearts following acute ischemia. Am J Physiol Regul Integr Comp Physiol 2009;296:R972-R978.
39. Iseki T, Yuki K. Postoperative consideration of diagnostic value of ultrasonography and excretory urography on seven patients with renal calculi. Hinyokika Kiyo 1988;34:1557-1560.
40. Galimberti RL, Villalba I, Galarza S, et al. Itraconazole in Pityriasis versicolor: ultrastructural changes in Malassezia furfur produced during treatment. Rev Infect Dis 1987;9(Suppl 1):S134-S138.
41. Bjornstrom L, Sjoberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 2005;19:833-842.
42. Jin X, Chen YC, Liu WQ, et al. Estradiol promote myocardial angiogenesis in a rat model of acute myocardial infarction through estrogen receptors. Sichuan Da Xue Xue Bao Yi Xue Ban. 2008;39:398-401.
43. Mahmoodzadeh S, Eder S, Nordmeyer J, et al. Estrogen receptor alpha up-regulation and redistribution in human heart failure. FASEB J 2006;20:926-934.
44. Kazi AA, Koos RD. Estrogen-induced activation of hypoxiainducible factor-1alpha, vascular endothelial growth factor expression, and edema in the uterus are mediated by the phosphatidylinositol 3-kinase/Akt pathway. Endocrinology 2007;148:2363-2374.
45. Dahm AE, Iversen N, Birkenes B, et al. Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1. BMC Cardiovasc Disord 2006;6:40.
46. Holroyd EW, Delacroix S, Larsen K, et al. Tissue factor pathway inhibitor blocks angiogenesis via its carboxyl terminus. Arterioscler Thromb Vasc Biol 2012;32:704-711.
47. Manavathi B, Nair SS, Wang RA, et al. Proline-, glutamic acid-, and leucine-rich protein-1 is essential in growth factor regulation of signal transducers and activators of transcription 3 activation. Cancer Res 2005;65:5571-5577.
48. Deschamps AM, Murphy E, Sun J. Estrogen receptor activation and cardioprotection in ischemia reperfusion injury. Trends Cardiovasc MED 2010;20:73-78.
49. Da Silva MB, Farges RC, Frode TS. Involvement of steroids in anti-inflammatory effects of PK11195 in a murine model of pleurisy. Mediators Inflamm 2004;13:93-103.
50. Lin J, Steenbergen C, Murphy E, et al. Estrogen receptor-beta activation results in S-nitrosylation of proteins involved in cardioprotection. Circulation 2009;120:245-254.